MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM— 510(k) K102077

Substantially Equivalent

Cma Microdialysis AB

FDA 510(k) clearance K102077 for MODIFICATION TO CMA CEREBRAL TISSUE MONITORING SYSTEM, Substantially Equivalent on 2011-01-14. Applicant: Cma Microdialysis AB.

Clearance details

Applicant: Cma Microdialysis AB
Product code: Code GWM
Advisory panel: Neurology
Date received: 2010-07-23
Decision date: 2011-01-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Chelmsford, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code GWM

product code GWM

Death: 21
Injury: 732
Malfunction: 2,063
Other: 1
Total: 2,817

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.